Free. Unsubscribe any time.
LIGAND PHARMACEUTICALS INC (LGND)
LIGAND PHARMACEUTICALS INC filed 20 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 111 transactions and 90,292 shares. None carries the SEC's AFF10B5ONE flag; all 20 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-08, came 25 days after the one before it (2026-08-14) and reports 5 transactions against 11 in the filing before it.
- The sales it reports total 5,000 shares, 26,641 fewer than the 31,641 in the filing before it.
- Its 20 plan statements rank 288th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 20 filings on file run from 2025-07-11 to 2026-09-08, and state no plan adoption date.
Trades in LIGAND PHARMACEUTICALS INC 111
- KOZARICH JOHN W — 2025-07-10 · S · 934 shares
- KOZARICH JOHN W — 2025-08-01 · S · 467 shares
- KOZARICH JOHN W — 2025-09-02 · S · 267 shares
- KOZARICH JOHN W — 2025-09-02 · S · 115 shares
- KOZARICH JOHN W — 2025-09-02 · S · 85 shares
- KOZARICH JOHN W — 2025-11-03 · S · 84 shares
- KOZARICH JOHN W — 2025-11-03 · S · 49 shares
- KOZARICH JOHN W — 2025-11-03 · S · 207 shares
- KOZARICH JOHN W — 2025-11-03 · S · 127 shares
- KOZARICH JOHN W — 2025-12-01 · S · 92 shares
- KOZARICH JOHN W — 2025-12-01 · S · 179 shares
- KOZARICH JOHN W — 2025-12-01 · S · 47 shares
Adoption dates in LIGAND PHARMACEUTICALS INC 0
Results prints in LIGAND PHARMACEUTICALS INC 7
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-02-26
- 2026-05-07
- 2026-08-06
Trades before a print in LIGAND PHARMACEUTICALS INC 14
- 3 days before the 2025-11-06 print — 2025-11-03 · S · KOZARICH JOHN W · 84 shares
- 3 days before the 2025-11-06 print — 2025-11-03 · S · KOZARICH JOHN W · 49 shares
- 3 days before the 2025-11-06 print — 2025-11-03 · S · KOZARICH JOHN W · 207 shares
- 3 days before the 2025-11-06 print — 2025-11-03 · S · KOZARICH JOHN W · 127 shares
- 3 days before the 2026-08-06 print — 2026-08-03 · S · Reardon Andrew · 105 shares
- 3 days before the 2026-08-06 print — 2026-08-03 · S · Reardon Andrew · 33 shares
- 3 days before the 2026-08-06 print — 2026-08-03 · S · Reardon Andrew · 157 shares
- 3 days before the 2026-08-06 print — 2026-08-03 · S · Reardon Andrew · 1,032 shares
- 3 days before the 2026-08-06 print — 2026-08-03 · S · Reardon Andrew · 1,214 shares
- 3 days before the 2026-08-06 print — 2026-08-03 · S · Reardon Andrew · 356 shares
- 3 days before the 2026-08-06 print — 2026-08-03 · S · Reardon Andrew · 503 shares
- 3 days before the 2026-08-06 print — 2026-08-03 · S · Reardon Andrew · 200 shares
Interval to LIGAND PHARMACEUTICALS INC’s next reported results date
How the interval and sources are counted →
- 14within 5 days
- 27within 10 days
- 3shortest, days
- 6no later print
- KOZARICH JOHN W 2025-08-01 · S · 6 days before the 2025-08-07 print
- KOZARICH JOHN W 2025-11-03 · S · 3 days before the 2025-11-06 print
- KOZARICH JOHN W 2025-11-03 · S · 3 days before the 2025-11-06 print
- KOZARICH JOHN W 2025-11-03 · S · 3 days before the 2025-11-06 print
- KOZARICH JOHN W 2025-11-03 · S · 3 days before the 2025-11-06 print
- KOZARICH JOHN W 2026-05-01 · S · 6 days before the 2026-05-07 print
- KOZARICH JOHN W 2026-05-01 · S · 6 days before the 2026-05-07 print
- KOZARICH JOHN W 2026-05-01 · S · 6 days before the 2026-05-07 print
- KOZARICH JOHN W 2026-05-01 · S · 6 days before the 2026-05-07 print
- KOZARICH JOHN W 2026-05-01 · S · 6 days before the 2026-05-07 print
- Reardon Andrew 2026-05-01 · S · 6 days before the 2026-05-07 print · CLO & Secretary
- Reardon Andrew 2026-05-01 · S · 6 days before the 2026-05-07 print · CLO & Secretary
- Reardon Andrew 2026-05-01 · S · 6 days before the 2026-05-07 print · CLO & Secretary
- Reardon Andrew 2026-05-01 · S · 6 days before the 2026-05-07 print · CLO & Secretary
- Reardon Andrew 2026-05-01 · S · 6 days before the 2026-05-07 print · CLO & Secretary
- Reardon Andrew 2026-05-01 · S · 6 days before the 2026-05-07 print · CLO & Secretary
- Reardon Andrew 2026-05-01 · S · 6 days before the 2026-05-07 print · CLO & Secretary
- Reardon Andrew 2026-08-03 · S · 3 days before the 2026-08-06 print · CLO & Secretary
- Reardon Andrew 2026-08-03 · S · 3 days before the 2026-08-06 print · CLO & Secretary
- Reardon Andrew 2026-08-03 · S · 3 days before the 2026-08-06 print · CLO & Secretary
Reported results dates on file
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-02-26
- 2026-05-07
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.